STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

STRATA Skin Sciences, Inc. will have its President and CEO, Dr. Dolev Rafaeli, present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference will take place from April 30 to May 2, 2024, at the Paris Hotel & Casino in Las Vegas, with Dr. Rafaeli's presentation scheduled for May 1, 2024, at 2:30 pm Pacific Time. Investors can also schedule one-on-one meetings with Dr. Rafaeli during the conference. Those unable to attend can access all company presentations on the conference event platform.

HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas.

Presentation Date:	May 1, 2024
Time:	2:30pm Pacific Time
Webcast Link:	https://www.webcaster4.com/Webcast/Page/3026/50402

Dr. Rafaeli will be available for one-on-one meetings throughout the conference. Investors can attend the conference and request a meeting with Dr. Rafaeli by registering at the link below:

https://planetmicrocapshowcase.com/signup

For investors who are unable to attend the conference, all company presentations will be available directly on the conference event platform on the “Agenda” tab at the link below:

https://planetmicrocapshowcase.com/agenda

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC^® excimer laser, VTRAC^® lamp systems, and the TheraClear^®X Acne Therapy System. STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Safe Harbor
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell an acne treatment device and to integrate that device into its product offerings, the Company’s ability to develop, launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to dermatologist marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from fiscal, political factors, international conflicts, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.

Investor Contact:
CORE IR
516-222-2560
ir@strataskin.com

FAQ

When will Dr. Dolev Rafaeli present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024?

Dr. Dolev Rafaeli will present on May 1, 2024, at 2:30 pm Pacific Time.

Where is the Planet MicroCap Showcase: VEGAS 2024 being held?

The conference is at the Paris Hotel & Casino in Las Vegas.

How can investors schedule one-on-one meetings with Dr. Rafaeli?

Investors can schedule meetings by registering at the provided link: https://planetmicrocapshowcase.com/signup.

How can those unable to attend the conference access company presentations?

All company presentations will be available on the conference event platform on the 'Agenda' tab at the link: https://planetmicrocapshowcase.com/agenda.